MY137249A - Aerosol formulation for inhalation containing a tiotropium salt - Google Patents

Aerosol formulation for inhalation containing a tiotropium salt

Info

Publication number
MY137249A
MY137249A MYPI20031314A MYPI20031314A MY137249A MY 137249 A MY137249 A MY 137249A MY PI20031314 A MYPI20031314 A MY PI20031314A MY PI20031314 A MYPI20031314 A MY PI20031314A MY 137249 A MY137249 A MY 137249A
Authority
MY
Malaysia
Prior art keywords
aerosol formulation
tiotropium salt
inhalation containing
inhalation
active substance
Prior art date
Application number
MYPI20031314A
Inventor
Drechsel Prof Dr Karin
Niklaushumke Dr Barbara
Schmelzer Dr Christel
Barth Petra
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28458728&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY137249(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY137249A publication Critical patent/MY137249A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Abstract

THE PRESENT INVENTION RELATES TO A PROPELLANT-FREE AEROSOL FORMULATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF TIOTROPIUM DISSOLVED IN WATER. THE FORMULATION ACCORDING TO THE INVENTION IS PARTICULARLY SUITABLE FOR NEBULISING THE ACTIVE SUBSTANCE USING AN ATOMISER IN ORDER TO ADMINISTER THE ACTIVE SUBSTANCE PREFERABLY TO TREAT THE INDICATIONS ASTHMA AND COPD BY INHALATION.
MYPI20031314A 2002-04-11 2003-04-09 Aerosol formulation for inhalation containing a tiotropium salt MY137249A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10216036A DE10216036A1 (en) 2002-04-11 2002-04-11 Aerosol formulation for inhalation containing a tiotropium salt

Publications (1)

Publication Number Publication Date
MY137249A true MY137249A (en) 2009-01-30

Family

ID=28458728

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20031314A MY137249A (en) 2002-04-11 2003-04-09 Aerosol formulation for inhalation containing a tiotropium salt

Country Status (33)

Country Link
EP (2) EP1496876B1 (en)
JP (1) JP2005531528A (en)
KR (1) KR100997219B1 (en)
CN (1) CN1309378C (en)
AR (1) AR039286A1 (en)
AT (1) ATE389391T1 (en)
AU (1) AU2003222791B2 (en)
BR (1) BR0309080A (en)
CA (1) CA2473815C (en)
CO (1) CO5611150A2 (en)
CY (1) CY1108133T1 (en)
DE (2) DE10216036A1 (en)
DK (1) DK1496876T3 (en)
EA (1) EA007228B1 (en)
EC (1) ECSP045358A (en)
ES (1) ES2303897T3 (en)
HK (1) HK1078793A1 (en)
HR (1) HRP20040932B1 (en)
ME (1) ME00359B (en)
MX (1) MXPA04009818A (en)
MY (1) MY137249A (en)
NO (1) NO334915B1 (en)
PE (1) PE20030970A1 (en)
PL (1) PL371204A1 (en)
PT (1) PT1496876E (en)
RS (1) RS50923B (en)
SA (1) SA03240192B1 (en)
SI (1) SI1496876T1 (en)
TW (1) TWI344851B (en)
UA (1) UA78994C2 (en)
UY (1) UY27754A1 (en)
WO (1) WO2003084519A2 (en)
ZA (1) ZA200405721B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1682541E (en) 2003-11-03 2010-04-14 Boehringer Ingelheim Int Method for producing tiotropium salts
JP2009504604A (en) * 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of tiotropium salt in the treatment of severe persistent asthma
US20070088030A1 (en) 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
EP1905440A1 (en) * 2006-09-06 2008-04-02 Boehringer Ingelheim Pharma GmbH & Co. KG Use of a pharmaceutical composition comprising an anticholinergic for killing microorganisms and for treating respiratory tract infections
EP2044967A1 (en) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Atomiser
WO2013127738A1 (en) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Novel propellant-gas-containing tiotropium formulation
RU2493827C1 (en) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Stable combined solution of fenoterol hydrobromide and ipratropium bromide
WO2015065223A1 (en) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Stable solution of fenoterol hydrobromide
WO2015065219A1 (en) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ipratropium bromide solution
GB201507686D0 (en) * 2015-05-05 2015-06-17 Norton Healthcare Ltd A stable tiotropium nebuliser solution
BR112019009278A2 (en) * 2016-11-16 2019-10-01 Glenmark Specialty S.A. method for administering tiotropium bromide and method for treating an inflammatory or obstructive airway disease
US20210290568A1 (en) * 2020-03-19 2021-09-23 Cai Gu Huang Inhalable formulation of a solution containing levalbuterol tartrate
CN114259481A (en) * 2021-11-26 2022-04-01 南京华盖制药有限公司 Compound inhalation solution of odaterol

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (en) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE19536903C2 (en) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Device for holding a fluidic component
DE19536902A1 (en) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Miniature fluid pressure generating device
DE19545226C1 (en) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Locking mechanism for a spring-operated output
DE19653969A1 (en) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg New aqueous pharmaceutical preparation for the production of propellant-free aerosols
DE19742439C1 (en) 1997-09-26 1998-10-22 Boehringer Ingelheim Int Fluid micro-filter
DE19847968A1 (en) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit.
EA007604B1 (en) * 2000-10-31 2006-12-29 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг Inhalative solution formulation containing a tiotropium salt

Also Published As

Publication number Publication date
BR0309080A (en) 2005-02-22
ECSP045358A (en) 2004-11-26
UY27754A1 (en) 2003-11-28
NO20044001L (en) 2004-10-27
MXPA04009818A (en) 2004-12-13
SI1496876T1 (en) 2008-08-31
AU2003222791B2 (en) 2008-09-25
ME00359B (en) 2011-10-10
CN1646108A (en) 2005-07-27
NO334915B1 (en) 2014-07-14
RS50923B (en) 2010-08-31
HK1078793A1 (en) 2006-03-24
PE20030970A1 (en) 2004-01-13
TWI344851B (en) 2011-07-11
EP1496876A2 (en) 2005-01-19
EA007228B1 (en) 2006-08-25
TW200401653A (en) 2004-02-01
CA2473815A1 (en) 2003-10-16
WO2003084519A2 (en) 2003-10-16
CO5611150A2 (en) 2006-02-28
WO2003084519A3 (en) 2003-12-24
HRP20040932B1 (en) 2013-04-30
ATE389391T1 (en) 2008-04-15
ZA200405721B (en) 2006-05-31
PT1496876E (en) 2008-04-15
KR20040097322A (en) 2004-11-17
EP1949892A1 (en) 2008-07-30
EP1496876B1 (en) 2008-03-19
HRP20040932A2 (en) 2005-02-28
MEP54308A (en) 2011-05-10
CY1108133T1 (en) 2014-02-12
DE10216036A1 (en) 2003-10-23
KR100997219B1 (en) 2010-11-29
CN1309378C (en) 2007-04-11
ES2303897T3 (en) 2008-09-01
DE50309414D1 (en) 2008-04-30
DK1496876T3 (en) 2008-06-02
AU2003222791A1 (en) 2003-10-20
SA03240192B1 (en) 2008-01-09
EA200401305A1 (en) 2005-06-30
RS87904A (en) 2006-12-15
JP2005531528A (en) 2005-10-20
CA2473815C (en) 2011-06-14
PL371204A1 (en) 2005-06-13
AR039286A1 (en) 2005-02-16
UA78994C2 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
MY137249A (en) Aerosol formulation for inhalation containing a tiotropium salt
US7767698B2 (en) Formulation and use thereof
DE60216588D1 (en) COMBINATION OF A PDE4 INHIBITOR WITH TIOTROPIUM FOR THE TREATMENT OF OBSTRUCTIVE RESPIRATORY DISEASES
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
RS76604A (en) Pressuriesed metered dose inhalers containing solutions of beta-2 agonists
AU2003243074A1 (en) A buffered, liquid nicotine composition for pulmonary administration
NO20054767L (en) Compositions comprising apomorphine for lung inhalation
HRP20120286T1 (en) Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
WO2017011729A1 (en) Combination therapies for the treatment of lung diseases
WO2008013929A3 (en) Anti-migraine oral spray formulations and methods
ES2300755T3 (en) SYNERGIC COMBINATION INCLUDING ROFLUMILAST AND AN ANTI-POLINERGIC AGENT SELECTED FROM TIOTROPIO SALTS FOR THE TREATMENT OF RESPIRATORY DISEASES.
WO2004012653A3 (en) Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
WO2021211858A8 (en) Inhalable formulation of a solution containing tiotropium bromide and olodaterol
YU33103A (en) Inhalative solution formulation containing a tiotropium salt
EP2253312A3 (en) Use of osmolytes obtained from extremophilic bacteria for the preparation of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device containing osmolytes as active agents
CA2653744C (en) Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
YU33003A (en) Inhalative solution formulation containing a tiotropium salt
JP2003502361A5 (en)
US20120101076A1 (en) Carbonate derivatives for the treatment of cough
WO2001062264A3 (en) Halotherapy method by inhalation of sodium chloride
KR20050094810A (en) Synergistic combination comprising roflumilast and (r,r)-formoterol
WO2022006028A3 (en) Pharmaceutical formulation containing combination of m3 antagonist-beta-2 agonist and inhaled corticosteroids